The old adage says that an apple a day keeps the doctor away, but new research from the University of Cincinnati shows the potential benefit of a different fruit for your health.
May 11, 2022
0
102
The rate of hypersensitivity reactions (HSRs) to gadolinium-based contrast agents (GBCAs) is 0.4 percent, and premedication can reduce the risk for HSRs in patients with a history of acute or delayed HSRs, according to a ...
May 4, 2022
0
2
A new study has prompted scientists to reconsider a once-popular yet controversial idea in stroke research.
Apr 21, 2022
0
113
Neuroscientists from St. Petersburg University, led by Professor Allan V. Kalueff, in collaboration with an international team of IT specialists, have become the first in the world to apply the artificial intelligence (AI) ...
Apr 14, 2022
0
36
The U.S. Food and Drug Administration approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for treatment of adults with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer ...
Apr 14, 2022
0
2
Effective combination therapies are urgently needed to treat triple-negative breast cancer (TNBC), which is insensitive to the existing treatment regimens. However, the synergistic potency of traditional small-molecule combinations ...
Apr 12, 2022
0
3
Antibiotics, together with antivirals and anti-parasitic drugs, can save the lives of people who've contracted an infectious disease. But the rise of drug-resistance means new strategies are needed. At the end of last year, ...
Apr 4, 2022
0
8
The presence of dendritic cells, so-called 'sentinel' immune cells, is vital to maintain and regulate the balance of the body's immune response. Researchers have discovered an essential role of these cells in the treatment ...
Apr 1, 2022
0
48
It is not possible to tell from the outside whether a wound will heal without problems under the dressing or whether bacteria will penetrate the injured tissue and ignite an inflammation. To be on the safe side, disinfectant ...
Mar 29, 2022
0
37
Researchers have discovered in mice an additional use of globins as an intravenous drug that can delay liver fibrosis progression. Last year, the application of recombinant human cytoglobin (CYGB) as a protein therapeutic ...
Mar 23, 2022
0
17
